TASR
TASR Articles
These are some of the top analyst Downgrades and negative calls we are seeing early this Friday morning: Abercrombie & Fitch (ANF) Cut to Neutral at Banc of America. Affymax (AFFY) Cut to Hold at...
Published:
Washington Mutual (WM) Concerns about the financial crisis burn like wildfire. Drops sharply to $6.14 from 52-week high of $44.19. AMBAC (ABK) Sells off to $2.02 after downgrades. The 52-week high...
Published:
A legal consortium of law firms has just filed suit on behalf of certain shareholders of TASER International Inc. (NASDAQ: TASR). Two Houston-based firms, The O’Quinn Law Firm and Christian Smith...
Published:
Sovereign Bancorp (SOV) Moody’s cuts rating. Drops to $6.48 from 52-week high of $24.71. Select Comfort (SCSS) Quarter short of expectation. Down to $2.45 from 52-week high of $19.03. Taser...
Published:
Below are the top analyst calls that a673b.bigscoots-temp.com is looking at this morning: Capella Education (NASDAQ: CPLA) started as Neutral at JPMorgan. Cephalon (NASDAQ: CEPH) raised to Strong Buy at...
Published:
Below is a snapshot of some of the key impact news affecting stocks in pre-market trading this Monday, January 7, 2008: AllianceBernstein (AB) noted as a hidden gem in Barron’s cover story. Answers...
Published:
Below is some of the top news pre-market: Applied Materials (AMAT) reports earnings after close; estimates are $0.29 EPS & R$2.38B. BEA Systems (BEAS) said it expects to submit SEC filings...
Published:
Last Updated:
Merriman upgrades Taser (TASR) from neutral to buy. Lehman (LEH) upgrades Motorola (MOT) from equal weight to overweight. Sun Trust starts Penn Virginia with a buy and $54 price target. Cowen...
Published:
TASER International, Inc. (TASR-NASDAQ) has announced a strategic alliance with iRobot Corp. (IRBT-NASDAQ) to develop a new robotic capability utilizing TASER(r) technologies. This combination of...
Published:
(AAPL) Apple’s iPhone launches tomorrow.(ABPI) Accentia Biopharma announced favorable interim blinded data on SinuNase in its fast-tracked pivotal Phase III clinical trial.(ALVR) Alvarion in pact...
Published:
(ANDW) Andrew Corp being acquired for $15.00 per share.(APOG) Apogee Enterprises $0.34 EPS vs $0.23e; unsure if comparable.(AUTH) AuthenTec priced its 7.5M share IPO at the top of the $9.00 to $11.00...
Published:
(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement in overall survival.(BAY) Bayer raised guidance on Schering...
Published:
(APPAD) AP Pharmaceuticals announces the pricing of its underwritten public offering of 21.2 million shares of its common stock at a public offering price of $1.65 per share.(BBND) Bigband Networks...
Published: